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Emerging data from high and upper middle income countries indicate that suicide rates 
generally did not increase during the initial months of the COVID-19 pandemic, yet the 
pandemic's impact on suicide is complex.  We discuss the nuances of this relationship, how it 
may evolve over time, and describe the specific steps that governments and societies must take to 
mitigate harm and prevent suicides in the late stages and aftermath of the pandemic. 
 



















The COVID-19 pandemic is among the most disruptive events to global health in living 
memory. Evidence has emerged of substantial negative mental health consequences, including 
possible increasing rates of suicidal thoughts (O’Connor et al., 2021; Winkler et al, 2020).  
Nationwide survey data from the first months of the pandemic in the United States showed 
increased mental distress, anxiety, depression, substance use, and suicidal thoughts in adults 
(Czeisler et al., 2020; Twenge & Joiner, 2020).  However, our group’s recent study of suicide 
mortality in 21 high- and upper-middle income countries during the pandemic’s first four months 
found no evidence of increased rates of suicide (Pirkis et al., 2021).  Indeed, there was evidence 
of decreases in national or regional suicide rates in nine countries (Australia, Canada, Chile, 
Ecuador, Germany, Japan, New Zealand, South Korea, United States) and no significant change 
in rates in the remaining 12 countries (Austria, Brazil, Croatia, England, Estonia, Italy, Mexico, 
Netherlands, Peru, Poland, Russia, and Spain) (Pirkis et al., 2021). Recently published data from 
China and India support these findings (Zheng et al., 2021; Behera et al., 2021).  Moreover, rates 
of outpatient and hospital presentations for self-harm have decreased in many regions during the 
early phase of the pandemic, suggesting a lower prevalence of medically serious suicidal 
behavior; though this might partly reflect the generally reduced use of healthcare services 
(Jollant et al., 2021; Carr et al., 2021; Knipe et al., in press). However, these findings should be 
viewed cautiously as they only pertain to the earliest months of the pandemic; it is unclear 
whether the observed trends will persist.  Notably, a sensitivity analysis which incorporated up to 
seven months of data from 18 of the countries identified increased suicide rates for three 
locations (Vienna (Austria), Puerto Rico, and Japan) (Pirkis et al., 2021).   
How should we interpret these seemingly contradictory findings and what are their 




complex, simultaneously affecting both risk and protective factors for suicidal behaviour (Figure 
1). On one hand, the pandemic has caused immense hardship arising from the effects of the 
disease itself, societal fear and uncertainty, prolonged isolation and physical distancing, 
disruption to education and school closure, economic hardship, increases in intimate 
partner/domestic violence, and bereavement. On the other hand, the collective trauma may also 
have normalised the experience of distress and resulted in a “coming together” phenomenon, as 
many individuals spend more time with their families and in their local communities. The 
pandemic has focused the public on survival and the collective hope that modern science will 
rescue the world with a vaccine. Hope, purpose, and belongingness may all lower the risk of 
suicide. These nuances may explain the counterintuitive increase in both suicidal thoughts and 
positive well-being reported in the UK (O’Connor et al., 2021).  Furthermore, emerging evidence 
indicates that the pandemic may disproportionately affect young people including US data 
showing an increase in emergency presentations for suspected suicide attempts in adolescent 
girls (O’Connor et al., 2021, Yard et al., 2021); while young people have higher rates of suicide 
attempts, in high income countries they generally have substantially lower rates of suicide death. 
Such findings might explain rising rates of mental health symptoms and suicidal thoughts 
without corresponding increases in suicide.  It should also be noted that deteriorating mental 
health has not been observed in all countries.  For example, the prevalence of mental disorders 
and suicidal ideation were unchanged in Norway during the first six months of the pandemic 
(Knudsen et al., 2021).  
Data from early phases of the pandemic demonstrate that hardship faced by people 
worldwide does not inevitably translate into increased suicide deaths, at least in higher income 




national suicide prevention strategies. That is important news which deserves broad attention. 
But lessons from previous pandemics suggest that we must avoid complacency (Zortea et al., in 
press). Mental health effects of the pandemic may increase over time due to prolonged economic 
stress and underemployment (Kawohl & Nordt, 2020) or post-infection increases in the 
prevalence of some psychiatric illnesses (Taquet et al., 2020). For example, in Japan, decreased 
suicide rates in the first four months of the pandemic were followed by a period with suicide 
rates that were higher than historical averages (Ueda et al., 2021). Moreover, in some locations 
where overall suicide rates were unchanged (or decreasing), there is concern about increased 
rates among youth, women and ethnic minorities (Ueda et al., 2021; Mitchell & Li, 2021). There 
is a clear need for continued monitoring of mental disorders and suicidal behaviour during the 
remainder of the pandemic and the protracted recovery period. This monitoring is especially 
necessary for low and middle income countries, given the dearth of existing data. It is also 
crucial given vaccine shortages that may prolong the pandemic and its impacts in these countries.   
 Proactive efforts to prevent suicide are, therefore, a current worldwide imperative.  
Robust, ongoing governmental and societal responses must include: 1) efforts to prevent and 
mitigate the negative effects of mass unemployment and economic hardship such as expanded 
unemployment and related social welfare programs; 2) actions to minimise the long-term damage 
to the career prospects of young people arising from disruptions to their education and to their 
transition to employment at a time of labour market upheaval, 3) timely access to high quality, 
evidence-based mental health treatment and suicide prevention interventions, including crisis 
helplines and services, with attention to the issue of diminished help-seeking during the 
pandemic; 4) public health and media messaging emphasizing healthy coping, emotional 




distress or an inevitable consequence of the pandemic; and 5) efforts to promote social cohesion 
with particular attention to places and times where societal divisions and/or discord may be 
emerging. A priority for the research community is also to evaluate which approaches have most 
effectively mitigated the pandemic’s impact on suicide rates to inform future responses to similar 
events. 
Unlike previous pandemics, COVID-19 is occurring in the modern digital world, where 
video conferencing and virtual healthcare provision are increasingly available. Public health 
advice based on real-time data and rapid development of vaccines have been demonstrated, while 
internationally coordinated economic mitigation strategies are now possible.  These conditions 
may shorten the duration of the pandemic and prevent a substantial number of COVID-19 deaths 
in many countries.  Preventing suicide during the remainder of the pandemic and its aftermath 
will likewise require robust, comprehensive efforts that address the diverse and rapidly changing 
conditions affecting risk in populations across the globe. 
All of these efforts must include specific steps to address suicide risk in youth, migrants, 
those with preexisting health and/or socioeconomic challenges, as well as people who have been 
infected with COVID-19 and professionals experiencing long-term stress (e.g. healthcare 
workers), since these groups may be particularly vulnerable (Iob et al., 2020). Lastly, and 
perhaps most importantly, the economic and mental health consequences of this pandemic will 
last well beyond its duration. We therefore urge governments and other stakeholders to begin 
planning immediately, if they have not already done so, for how the strategies above will be 
maintained in the aftermath of the pandemic and what culturally-appropriate steps can be taken 
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Figure 1: Potential Risk and Protective Factors that may Influence Suicide Rates during the 
COVID-19 Pandemic 
 
